3-Isoxazolecarboxamide, 5-(2-furanyl)-N-[2-(1H-pyrazol-1-yl)ethyl]- manufacturers
|
| | 3-Isoxazolecarboxamide, 5-(2-furanyl)-N-[2-(1H-pyrazol-1-yl)ethyl]- Basic information |
| | 3-Isoxazolecarboxamide, 5-(2-furanyl)-N-[2-(1H-pyrazol-1-yl)ethyl]- Chemical Properties |
| Boiling point | 533.9±50.0 °C(Predicted) | | density | 1.42±0.1 g/cm3(Predicted) | | storage temp. | 4°C, protect from light | | solubility | DMSO : 50 mg/mL (183.65 mM; Need ultrasonic) | | form | Solid | | pka | 13.13±0.46(Predicted) | | color | White to off-white |
| | 3-Isoxazolecarboxamide, 5-(2-furanyl)-N-[2-(1H-pyrazol-1-yl)ethyl]- Usage And Synthesis |
| Uses | Wnt/β-catenin agonist 2 is a potent Wnt agonist. Wnt/β-catenin agonist 2 activates Wnt/β-catenin signaling and can be used in the research of diseases related to the signal transduction[1]. (From patent WO2007078113A1, compound 39) | | Biological Activity | Wnt/β-catenin agonist 2 is a potent Wnt agonist. Wnt/β-catenin agonist 2 activates Wnt/β-catenin signaling and can be used in the research of diseases related to the signal transduction[1]. (From patent WO2007078113A1, compound 39)
Wnt/β-catenin agonist 2 is a activator for β-Catenin in SW480 cell line. Wnt/β-catenin agonist 2 shows effect on differentiation ST2 Cell into osteoblasts[1]. | | References | [1]. Jeong Woo Cho, et al. Isoxazole derivatives and use thereof. WO2007078113A1. |
| | 3-Isoxazolecarboxamide, 5-(2-furanyl)-N-[2-(1H-pyrazol-1-yl)ethyl]- Preparation Products And Raw materials |
|